TrialScope Blog

Thomas Wicks

Noncompliant Clinical Trial Transparency

JUNE 6, 2017 OVERVIEW: Regulatory Risk is the possibility that changing regulations will significantly affect the organization, requiring additional investments, changes in operations, or other adjustments

Expanding Transparency

MAY 12, 2017 The growing scope of global disclosure Global Disclosure Clinical trials are conducted in almost every country in the world, each with its

EudraCT Results Reporting

DECEMBER 9, 2014 In October 2014, the European Medicines Agency published its final policy on publication of clinical trial data. Prior to finalization and during the public